310417
4-(溴甲基)苯乙酸
95%
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
BrCH2C6H4CH2CO2H
化学文摘社编号:
分子量:
229.07
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
2360711
Assay:
95%
Form:
solid
产品名称
4-(溴甲基)苯乙酸, 95%
InChI
1S/C9H9BrO2/c10-6-8-3-1-7(2-4-8)5-9(11)12/h1-4H,5-6H2,(H,11,12)
SMILES string
OC(=O)Cc1ccc(CBr)cc1
InChI key
WCOCCXZFEJGHTC-UHFFFAOYSA-N
assay
95%
form
solid
mp
179-183 °C (lit.)
正在寻找类似产品? 访问 产品对比指南
Application
丝氨酸蛋白酶抑制剂的前体。用于合成新型冠醚受体。
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
法规信息
新产品
此项目有
R Rai et al.
Journal of medicinal chemistry, 35(23), 4297-4305 (1992-11-13)
Previously, we have reported that some guanidino-substituted alpha- and beta-aryl enol lactones I and II behaved as selective, mechanism-based inhibitors of some trypsin-like proteases (Rai, R.; Katzenellenbogen, J.A. J. Med. Chem., submitted). In this study, we describe the synthesis and
Zhiqiang Feng et al.
Bioorganic & medicinal chemistry letters, 19(8), 2270-2272 (2009-03-17)
We have developed a novel and moderately selective COX-2 inhibitor, imrecoxib, as a new anti-inflammatory drug. We describe herein the preparation of the major metabolites M2 and M4 of imrecoxib, as well as the in vitro and in vivo activities
Journal of the Chemical Society. Chemical Communications, 399-399 (1993)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持